Source: Breathe, 14 (3) 176; 10.1183/20734735.021118
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mark Rosenthal. Never mind the biologics, just take the inhalers. Breathe, 14 (3) 176; 10.1183/20734735.021118

Member's Comments

No comment yet.

Related content which might interest you: Not all inhalers are the same: factors to consider when prescribing a new device inhaler Source: Annual Congress 2010 - The essentials of aerosol therapy: what the practicing physician should know Year: 2010 The challenge of new inhalers Source: International Congress 2018 – Primary Care Programme 2018: Part II Year: 2018 How does the Novolizer fit into the choice of inhaler? Source: Annual Congress 2005 - Asthma management - important issues Year: 2005 Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)? Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005 How patients use inhalers - what are the critical errors? Source: International Congress 2017 – Advances in Inhaler technology - intuitive design and better drug delivery Year: 2017 Misuse of inhalers devices in clinical practice Source: International Congress 2017 – COPD management Year: 2017 What are the key issues in the inhaler therapy in children? Source: Annual Congress 2004 - How can we improve asthma management? Year: 2004 Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability Source: Eur Respir J 2002; 19: 246-251 Year: 2002 Correct and incorrect use of metered dose inhalers by patients and related factors Source: Annual Congress 2007 - Nursing interventions in the prevention and management of respiratory disease Year: 2007 Switch to Budesonide/Formoterol Easyhaler Inhalation from other inhalers in asthma patients; A real-life study Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Comparison between traditional and nontraditional add-on devices used with pressurised metered-dose inhalers Source: ERJ Open Res, 6 (4) 00073-2020; 10.1183/23120541.00073-2020 Year: 2020 Key attributes of inhalers for patients versus physicians Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Ten questions about metered dose inhalers: the quality of patient‘s knowledge about aerosol therapy Source: Eur Respir J 2005; 26: Suppl. 49, 514s Year: 2005 How can we improve patient use of inhaler devices in COPD? Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Handling of inhalers by COPD patients in actual clinical practice Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 How to select an inhaler? Source: Virtual Congress 2020 – Inhalers for COPD and asthma: reviews Year: 2020 Once-daily budesonide: clinical equivalence of two dry powder inhalers (DPIs) Source: Eur Respir J 2005; 26: Suppl. 49, 339s Year: 2005 Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Technique training doesn‘t improve patients ability to use pressurised metered dose inhalers (pMDIs) Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009